Received Sep 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (FLUZONE) | SANOFI PASTEUR | 1 | UT8792LA | OT |
Received vaccine during pregnancy, with no reported adverse event; Initial information received on 04-Sep-2025 regarding an unsolicited valid non-serious case received from a nurse. This case involves a 28 years old pregnant female patient who was exposed to Influenza Usp Trival A-B Subvirion No Preservative Vaccine [Fluzone] during pregnancy, with no reported adverse event. Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known. The reported Received vaccine during pregnancy, with no reported adverse event occurred at 29 weeks of pregnancy and the patient was exposed to Influenza Usp Trival A-B Subvirion No Preservative Vaccine at 29 weeks of pregnancy, during third pregnancy trimester. The date of last menstrual period was reported as 17-Feb-2025. The estimated due date is 17-Nov-2025. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. The patient had unknown previous pregnancy/ies. On 04-Sep-2025, the pregnant patient received 1DF(dosage form) (Dose 1) of suspect Influenza Usp Trival A-B Subvirion No Preservative Vaccine, Suspension for injection (lot UT8792LA, expiry date and strength not reported) via intramuscular route in unknown administration site for prophylactic vaccination (Immunisation) and vaccine during pregnancy, with no reported adverse event (exposure during pregnancy) (latency same day). Action taken was not applicable. Additionally, at time of reporting, the pregnancy is still ongoing.